About
Superpower, founded in 2021 in Los Angeles, offers at-home blood testing services and a mobile app to help users track and improve their long-term health.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2025-04Series A$30M
Investors · Susa Ventures, Day One Ventures, Valia Ventures, Forerunner Ventures, Family Fund, Visible Ventures, Winklevoss Capital, Long Journey Ventures, Opal VenturesSource · SVTR Weekly #102
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Superpower
At-home blood testing with a mobile app to track and improve long-term health
Series A · $30M · 2025-04
$30M
United States
BusinessLatest roundTotal raisedDate- Inito
At-home fertility hormone tests using AI-designed antibodies
Series B · $29M · 2025-12
$29M - Adaptive Innovation
AI system for home health visits that automates patient intake, scheduling, clinical documentation and compliant billing
Series A · $60M · 2026-06
$60M - Flourish Health
Psychiatrist-led intensive in-home care for youth with serious, complex mental health conditions such as depression, anxiety and bipolar disorder, combining in-person home support with virtual visits, with a proprietary AI platform coordinating care delivery and partnerships with large US health plans.
Series A · $46M · 2026-07
$46M
China
BusinessLatest roundTotal raisedDate- Renerval Biotherapeutics
iPSC-based artificial blood (regenerated platelets/red blood cells) and off-the-shelf cell therapies: R&D and scaled manufacturing
Series A · $21M · 2026-08
$21M - 格式塔科技
Ultrasound brain-computer interface for whole-brain read/write, treating chronic pain, stroke rehabilitation, PTSD and other neurological conditions
Angel · $80M · 2026-07
$80M - Drug Farm
Drug developer using genetics and AI to discover first-in-class targets
Series D+ · $55M · 2026-07
$55M
Europe
BusinessLatest roundTotal raisedDate- Flok Health
AI-run physical therapy that diagnoses, triages, treats and discharges musculoskeletal patients for health systems via mobile consultations
Series A · $13M · 2026-06
$13M - Voize
AI voice documentation assistant for frontline nursing that generates standardized nursing records automatically
Series A · $59M · 2025-11
$59M - Corti
Uses AI to assess patients in collaboration with clinicians
Series B · $60M · 2023-09
$60M
Other / unspecified
BusinessLatest roundTotal raisedDate- Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M - AssistIQ
Uses AI to help hospitals track surgical supplies to reduce costs
Series A · $12M · 2025-05
$12M - Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing), with a company-operated network of hospitals and clinics and accompanying health insurance.
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 26 at a nearby stage · 36 in Greater LA
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 33 at a nearby stage · 31 in Greater LA
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 12 at a nearby stage · 22 in Greater LA
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 10 at a nearby stage · 20 in Greater LA
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 6 at a nearby stage · 15 in Greater LA
Request intro →Lightspeed
17 Life Sciences deals in the last 24 months · 11 at a nearby stage · 15 in Greater LA
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.